Seeing is Believing
Researchers from the Kennedy Krieger Institute and four collaborating institutions have identified an unexpected biological pathway that may contribute to glaucoma.
HPV Vaccination May be Your Best Shot
To ring in Cervical Health Awareness Month, let's start with a rather startling statistic: Did you know cervical cancer ranks as the third most common cancer in women worldwide?
Timing is Everything
There may be no greater boon to combating cancer than diagnosing the disease in its earliest and most treatable stages. Exciting new technologies that detect cancer in faster, smarter ways are making sure that happens.
War's Effects on the Brain
Soldiers returning from combat experience more complications due to PTSD than concussions, a recent study finds.
A Healthy Baby New Year
For most women, finding out they are pregnant is a joyous occasion, full of hope and happiness. But along with that happiness can also be stress and worry, hoping that the baby growing inside of them will be delivered healthy and without complications. There are many questions to answer and much information to gather...what vitamins to take? What should she eat? Should she continue to take her prescribed medication? To help answer these questions for all expectant mothers and women thinking about having a baby, the National Birth Defects Prevention Network (NBDPN) wants everyone to kno...
Nearly a decade's worth of studies on a "depression gene" have been examined by the University of Michigan and their findings point to a definite genetic link to depression and anxiety.
Medical Scans Pose Higher Risk for Children
The frequency of children undergoing medical imaging tests that use radiation is becoming a concern, due to potential cancer risks associated with multiple procedures.
Radiosurgery Makes Waves
Trigeminal neuralgia, a painful condition occurring in patients with multiple sclerosis (MS), can be effectively treated with stereotactic radiation (radiosurgery), a specialized radiation therapy that focuses radiation beams on a well-defined area.
A Tale of Two Treatments
Researchers at Boston University School of Medicine found little difference in the efficacy of the treatments Bevacizumab (Avastin) and Ranibizumab (Lucentis), used to treat age-related macular degeneration (AMD).
Congenital defects and certain cancers are caused by malfunctioning stem cells, even before birth.